谷歌浏览器插件
订阅小程序
在清言上使用

Extended Follow‐up and the Feasibility of Panobinostat Maintenance for Patients with Relapsed Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone Plus Panobinostat (MUK Six Open Label, Multi‐centre Phase I/II Clinical Trial)

BRITISH JOURNAL OF HAEMATOLOGY(2019)

引用 7|浏览3
关键词
myeloma,clinical trials,myeloma therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要